North America Upstream Bioprocessing Market Forecast to 2030
North America Upstream Bioprocessing Market Forecast to 2030 – Regional analysis – by Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single-use and Multi-use), and Mode (In-house and Outsourced)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Commercial Use of Single-Use Bioreactors Fuels North America Upstream Bioprocessing Market.
Various manufacturers are developing single-use bioreactors (SUBs) due to their robust build and high performance, which are necessary for the commercial manufacturing of biopharmaceuticals. The incorporation of technologies associated with biofilm formation, stirring mechanisms, bioreactor designs, and sensor systems, among others, have resulted in the increased adoption of disposable reactors at the laboratory and production scales. Single-use bioreactors are operated to manufacture next-generation cell and gene therapies, and they are suitable for continuous bioprocessing. Advancements in cell-culture processes have developed higher titers and cell densities, facilitating the adoption of SUBs. Single-use bioreactors operate with a low risk of contamination, shorter production turnaround times, and reduced validation time. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to aid enhanced flexibility, reduce investments, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. In March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors. Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The use of single-use bioreactors is subsequently increasing in upstream bioprocessing. Thus, the increasing acceptance of single-use bioreactors for the production of therapeutics propels the upstream bioprocessing market.
North America Upstream Bioprocessing Market Overview
The upstream bioprocessing market in North America is segmented into the US, Canada, and Mexico. Market growth in North America is attributed to the increasing demand for bioreactor systems from biopharmaceutical and biotechnology companies, the prominent presence of market players, and growing R&D efforts by academic and research institutes. In addition, research activities by pharmaceutical and biotechnology companies propel the upstream bioprocessing market growth in North America.
North America Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)
North America Upstream Bioprocessing Market Segmentation
The North America upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country.
Based on product type, the North America upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.
Based on workflow, the North America upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.
In terms of usage type, the North America upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022
By mode, the North America upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.
Based on country, the North America upstream bioprocessing market is segmented into the US, Canada, and Mexico. The US dominated the North America upstream bioprocessing market share in 2022.
Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, Entegris Inc, and PBS Biotech Inc are some of the leading companies operating in the North America upstream bioprocessing market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the North America upstream bioprocessing market was valued at US$ 3,958.62 million in 2022 and is expected to reach US$ 10,603.38 million by 2030, registering a CAGR of 13.1% from 2022 to 2030. Increasing investments in R&D in biopharmaceutical industry and technological advancements are among the critical factors attributed to the North America upstream bioprocessing market expansion.
Increasing investments in research and development (R&D) in the biopharmaceutical industry are likely to bring new trends into the upstream bioprocessing market in the coming years. In March 2020, Culture Biosciences announced securing the funds of US$ 15 million (13.4 million) in the Series A investment round, citing the backing of new and existing venture capital backers. According to Culture Biosciences, the money has been used to treble the capacity of bioreactors as well as to develop more cloud-based software monitoring and development tools for biomanufacturing research and development. The company states that this investment will help scientists manage their whole R&D workflow via software applications, hence supporting the digitization of biomanufacturing R&D.
As R&D investments continue to surge, particularly in novel biologics, advanced therapies, and personalized medicine, there is a parallel emphasis on optimizing upstream bioprocessing technologies and methodologies. This trend is leading to the development of innovative bioreactor systems, cell culture media formulations, and process automation solutions to enhance the efficiency, scalability, and productivity of biopharmaceutical production operations. Furthermore, the focus on R&D investments favors the development of cutting-edge bioprocessing platforms that cater to the evolving landscape of biopharmaceuticals, including next-generation therapeutic modalities and biosimilars. Additionally, dedicating R&D funds for bioprocessing trends such as continuous bioprocessing and advanced analytics for process monitoring is expected to reshape the future of upstream bioprocessing, driving the adoption of state-of-the-art technologies and establishing new benchmarks for process performance, quality, and regulatory compliance.
On the contrary, stringent regulatory framework hampers the growth of North America upstream bioprocessing market.
Based on product type, the North America upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters segment held 35.1% market share in 2022, amassing US$ 1,390.54 million. It is projected to garner US$ 3,692.55 million by 2030 to expand at 13.0% CAGR during 2022-2030.
Based on workflow, the North America upstream bioprocessing market is segmented into media preparation, cell culture, and cell separation. The cell separation segment held 40.1% share of North America upstream bioprocessing market in 2022, amassing US$ 1,586.39 million. It is projected to garner US$ 4,438.70 million by 2030 to expand at 13.7% CAGR during 2022-2030.
By usage type, the North America upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use segment held 55.2% share of North America upstream bioprocessing market in 2022, amassing US$ 2,183.60 million. It is projected to garner US$ 5,950.88 million by 2030 to expand at 13.4% CAGR during 2022-2030.
In terms of mode, the North America upstream bioprocessing market is bifurcated into In-house and outsourced. The outsourced segment held 59.3% share of North America upstream bioprocessing market in 2022, amassing US$ 2,346.30 million. It is projected to garner US$ 6,163.04 million by 2030 to expand at 12.8% CAGR during 2022-2030.
Based on country, the North America upstream bioprocessing market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.2% share of North America upstream bioprocessing market in 2022. It was assessed at US$ 3,293.97 million in 2022 and is likely to hit US$ 8,989.60 million by 2030, exhibiting a CAGR of 13.4% during 2022-2030.
Key players operating in the North America upstream bioprocessing market are Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, Entegris Inc, and PBS Biotech Inc, among others.
In February 2022, Thermo Fisher Scientific in announced expansion for its Bioprocessing. The company has invested US$40 million to construct and maintain a manufacturing plant for single-use technologies in Millersburg, Pennsylvania. The expansion was a part of a multiyear, US$ 650 million investment to improve the company’s capacity to produce bioprocessing in a flexible, scalable, and dependable manner.
In January 2023, Sartorius collaborated with RoosterBio Inc to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. Through this collaboration, Sartorius and RoosterBio will provide best-in-class solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) – based exosome production platform that delivers industry-leading yield, purity, and potency.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America upstream bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Upstream Bioprocessing Market Landscape
4.1 Overview
4.2 PEST Analysis
5. North America Upstream Bioprocessing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Commercial Use of Single-Use Bioreactors
5.1.2 Outsourcing of Biopharmaceutical Manufacturing
5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
5.2 Market Restraints
5.2.1 Stringent Regulatory Framework
5.3 Market Opportunities
5.3.1 Technological Advancements
5.4 Future Trends
5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
5.5 Impact of Drivers and Restraints:
6. Upstream Bioprocessing Market – North America Analysis
7. North America Upstream Bioprocessing Market Analysis – by Product Type
7.1 Bioreactors/Fermenters
7.1.1 Overview
7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Cell Culture
7.2.1 Overview
7.2.2 Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Filters
7.3.1 Overview
7.3.2 Filters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Bags and Containers
7.4.1 Overview
7.4.2 Bags and Containers: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Upstream Bioprocessing Market Analysis – by Workflow
8.1 Media Preparation
8.1.1 Overview
8.1.2 Media Preparation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Cell Culture
8.2.1 Overview
8.2.2 Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Cell Separation
8.3.1 Overview
8.3.2 Cell Separation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Upstream Bioprocessing Market Analysis – by Usage Type
9.1 Single-use
9.1.1 Overview
9.1.2 Single-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Multi-use
9.2.1 Overview
9.2.2 Multi-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Upstream Bioprocessing Market Analysis – by Mode
10.1 In-house
10.1.1 Overview
10.1.2 In-house: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Outsourced
10.2.1 Overview
10.2.2 Outsourced: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11. North America Upstream Bioprocessing Market – Country Analysis
11.1 North America Market Overview
11.1.1 North America: Upstream Bioprocessing Market – Revenue and Forecast Analysis – by Country
11.1.1.1 North America: Upstream Bioprocessing Market – Revenue and Forecast Analysis – by Country
11.1.1.2 US
11.1.1.3 US: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 US: Upstream Bioprocessing Market Breakdown, by Product Type
11.1.1.3.2 US: Upstream Bioprocessing Market Breakdown, by Workflow
11.1.1.3.3 US: Upstream Bioprocessing Market Breakdown, by Usage Type
11.1.1.3.4 US: Upstream Bioprocessing Market Breakdown, by Mode
11.1.1.4 Canada
11.1.1.5 Canada: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Canada: Upstream Bioprocessing Market Breakdown, by Product Type
11.1.1.5.2 Canada: Upstream Bioprocessing Market Breakdown, by Workflow
11.1.1.5.3 Canada: Upstream Bioprocessing Market Breakdown, by Usage Type
11.1.1.5.4 Canada: Upstream Bioprocessing Market Breakdown, by Mode
11.1.1.6 Mexico
11.1.1.7 Mexico: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.7.1 Mexico: Upstream Bioprocessing Market Breakdown, by Product Type
11.1.1.7.2 Mexico: Upstream Bioprocessing Market Breakdown, by Workflow
11.1.1.7.3 Mexico: Upstream Bioprocessing Market Breakdown, by Usage Type
11.1.1.7.4 Mexico: Upstream Bioprocessing Market Breakdown, by Mode
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Upstream Bioprocessing Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Esco Micro Pte. Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Danaher Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Corning Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Entegris, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 PBS Biotech, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams
14.2 Glossary of Terms
Table 1. Upstream Bioprocessing Market Segmentation
Table 2. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Product Type
Table 3. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Workflow
Table 4. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Usage Type
Table 5. Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million) – by Mode
Table 6. North America: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 7. US: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Product Type
Table 8. US: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Workflow
Table 9. US: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Usage Type
Table 10. US: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Mode
Table 11. Canada: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Product Type
Table 12. Canada: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Workflow
Table 13. Canada: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Usage Type
Table 14. Canada: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Mode
Table 15. Mexico: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Product Type
Table 16. Mexico: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Workflow
Table 17. Mexico: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Usage Type
Table 18. Mexico: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million) – by Mode
Table 19. Recent Organic Growth Strategies in Upstream Bioprocessing Market
Table 20. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
Table 21. Glossary of Terms, Upstream Bioprocessing Market
Figure 1. Upstream Bioprocessing Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Upstream Bioprocessing Market – Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
Figure 6. Upstream Bioprocessing Market Share (%) – by Product Type (2022 and 2030)
Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Filters: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Bags and Containers: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Upstream Bioprocessing Market Share (%) – by Workflow (2022 and 2030)
Figure 13. Media Preparation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Cell Culture: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Cell Separation: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Upstream Bioprocessing Market Share (%) – by Usage Type (2022 and 2030)
Figure 17. Single-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Multi-use: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Upstream Bioprocessing Market Share (%) – by Mode (2022 and 2030)
Figure 20. In-house: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Outsourced: Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. North America Upstream Bioprocessing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. North America: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. US: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. Canada: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. Mexico: Upstream Bioprocessing Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Growth Strategies in Upstream Bioprocessing Market
The List of Companies – North America Upstream Bioprocessing Market
1. Thermo Fisher Scientific Inc
2. Esco Micro Pte Ltd
3. Sartorius AG
4. Danaher Corp
5. Getinge AB
6. Merck KGaA
7. Corning Inc
8. Entegris Inc
9. PBS Biotech Inc-NA.
You must be logged in to post a review.
Reviews
There are no reviews yet.